Dosed a first patient in a company-sponsored global Phase 2 clinical trial evaluating darovasertib as neoadjuvant and adjuvant therapy in primary uveal.
Blackbird, AirTree and Square Peg are the big name local VCs, but none of them run a fund that is half the size of the mammoth $2 billion Breakthrough Victoria.
IDEAYA Biosciences, Inc Reports Second Quarter 2023 Financial Results and Provides Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Designed by leading architectural practice Lyons, the fantastic transformation of the hospital features Atkar s exceptional acoustic linings to perfectly complement the outstanding interiors.
Eye preservation reported for the first UM patient treated with darovasertib monotherapy under the amended IST protocol enabling neoadjuvant treatment up to 6.